ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,57
0,39%
Bitcoin
95 287,00
-4,04%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Cours

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0,082
0,00
(0,00%)
Fermé 26 Décembre 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,082
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,35
Cap du marché
9,871M
Clôture Veille
0,082
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
34 392
Actions en circulation
120 377 529
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,68
Bénéfice par action (BPA)
-0,05
Chiffre d'affairess
35,43M
Bénéfice net
-5,74M

À propos de Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.parnell.com
Siège social
Sydney, New South Wales, Aus
Fondé
-
Parnell Pharmaceuticals Holdings Ltd (CE) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker PARNF. Le dernier cours de clôture d'Parnell Pharmaceuticals (CE) était de US$0,08. Au cours de la dernière année, les actions de Parnell Pharmaceuticals (CE) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,35.

Parnell Pharmaceuticals (CE) compte actuellement 120 377 529 actions en circulation. La capitalisation boursière d'Parnell Pharmaceuticals (CE) est de US$9,87 million. Parnell Pharmaceuticals (CE) a un ratio cours/bénéfice (ratio PE) de -1.68.

PARNF Dernières nouvelles

Plus de nouvelles

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

19 Décembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

09 Décembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

23 Novembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

02 Novembre 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

27 Octobre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

04 Août 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

26 Juillet 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

31 Mai 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

12 Mai 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

22 Avril 2016
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.268-76.57142857140.350.350.082293590.10951122CS
40.032640.050.350.05343920.06693432CS
120.032640.050.350.05343920.06693432CS
260.0819819000.00010.351.0E-6211350.06535084CS
520.08199981999001.0E-60.351.0E-6136910.06305566CS
1560.0818409000.00020.351.0E-6128800.01724424CS
260-0.038-31.66666666670.120.891.0E-6126870.21105413CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?
The current share price of Parnell Pharmaceuticals (CE) is US$ 0,082
How many Parnell Pharmaceuticals (CE) shares are in issue?
Parnell Pharmaceuticals (CE) has 120 377 529 shares in issue
What is the market cap of Parnell Pharmaceuticals (CE)?
The market capitalisation of Parnell Pharmaceuticals (CE) is USD 9,87M
What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?
Parnell Pharmaceuticals (CE) has traded in the range of US$ 0,000001 to US$ 0,35 during the past year
What is the PE ratio of Parnell Pharmaceuticals (CE)?
The price to earnings ratio of Parnell Pharmaceuticals (CE) is -1,68
What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?
The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0,27
What is the reporting currency for Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) reports financial results in AUD
What is the latest annual turnover for Parnell Pharmaceuticals (CE)?
The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35,43M
What is the latest annual profit for Parnell Pharmaceuticals (CE)?
The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5,74M
What is the registered address of Parnell Pharmaceuticals (CE)?
The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
What is the Parnell Pharmaceuticals (CE) website address?
The website address for Parnell Pharmaceuticals (CE) is www.parnell.com
Which industry sector does Parnell Pharmaceuticals (CE) operate in?
Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CLGPFClean Seed Cap Group Limited (CE)
US$ 0,05
(4 999 900,00%)
59,7k
EWGFFEat Well Investment Group Inc (CE)
US$ 0,03
(2 999 900,00%)
90,12k
EGSEEvergreen Sustainable Enterprises Inc (CE)
US$ 0,0007
(69 900,00%)
150
FBECFBEC Worldwide Inc (CE)
US$ 0,0005
(49 900,00%)
10k
HLCOHealing Company Inc (CE)
US$ 0,0005
(49 900,00%)
8k
GTMIFGastem Inc (CE)
US$ 0,000001
(-100,00%)
110k
QGRSFQ2 Gold Resources Inc (CE)
US$ 0,000001
(-99,90%)
13,48k
STTOSITO Mobile Ltd (CE)
US$ 0,000002
(-99,82%)
4,09k
CRGPCalissio Resources Group Inc (CE)
US$ 0,000001
(-99,75%)
3,97k
RLBDReal Brands Inc New (CE)
US$ 0,000001
(-99,00%)
694,31k
HMBLHUMBL Inc (PK)
US$ 0,0008
(14,29%)
312,88M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(-50,00%)
131,64M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
112,89M
DNAXDNA Brands Inc (PK)
US$ 0,0002
(0,00%)
74,37M
GTVHGolden Triangle Ventures Inc (PK)
US$ 0,0005
(25,00%)
67,86M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
PARNF
Parnell Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés